RSK inhibitor FMK
allosteric C-terminal kinase domain-targeting compound
Also Known As:
1-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo(2,3-d)pyrimidin-6-yl)-2-fluoroethanone
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Jin, Lingtao:
2 articles
(11/2013 - 06/2011)
|
| 2. | Kang, Sumin:
2 articles
(11/2013 - 06/2011)
|
| 3. | Lee, Benjamin H:
2 articles
(11/2013 - 06/2011)
|
| 4. | Taunton, Jack:
2 articles
(11/2013 - 06/2011)
|
| 5. | Alesi, Gina N:
1 article
(11/2013)
|
| 6. | Chen, Zhuo G:
1 article
(11/2013)
|
| 7. | Fan, Jun:
1 article
(11/2013)
|
| 8. | Gu, Ting-Lei:
1 article
(11/2013)
|
| 9. | Khuri, Fadlo R:
1 article
(11/2013)
|
| 10. | Kim, Young-Mee:
1 article
(11/2013)
|